We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics...
Ascletis Pharma Inc. (HKEX code: 1672) announces today the first clinical study using Ganovo®(danoprevir) to treat naive and experienced COVID-19 patients was published in medRxiv.
Chinese medical experts have emphasized using different therapies to treat patients with different symptoms of the novel coronavirus disease (COVID-19).
Vice-Premier Sun Chunlan has reiterated the need to make all-out efforts to save COVID-19 patients in Central China's Hubei province, stressing scientific and precise treatment.